Description

Gliempaflozin 3D 10 is a combination antidiabetic medicine containing empagliflozin 10 mg, sitagliptin 100 mg, and metformin hydrochloride 1000 mg. It is intended to help manage blood glucose levels in adults with type 2 diabetes mellitus when prescribed by a qualified healthcare professional. These three active ingredients work through different mechanisms to support glycaemic control. Empagliflozin helps the kidneys eliminate excess glucose through urine, sitagliptin supports incretin hormone activity, and metformin reduces glucose production in the liver while improving insulin sensitivity. This medicine should be used alongside a balanced diet, regular exercise, and appropriate medical supervision. Uses Gliempaflozin 3D 10 is primarily used for managing type 2 diabetes mellitus. Its main uses include: Helping lower elevated blood glucose levels. Supporting improvement in HbA1c, which reflects average blood sugar levels over time. Providing combination treatment when a healthcare professional determines that multiple medicines are necessary. Supporting long-term diabetes management alongside lifestyle modifications. It is not intended to treat type 1 diabetes or diabetic ketoacidosis. Its suitability depends on the patient's medical history, kidney function, and current diabetes treatment. Benefits Gliempaflozin 3D 10 combines three active ingredients to support blood sugar management through complementary mechanisms. Empagliflozin increases urinary glucose excretion, sitagliptin helps regulate glucose-dependent insulin release, and metformin decreases hepatic glucose production. Potential benefits include improved glycaemic control, support for individual blood sugar targets, and convenience through a combination formulation. Empagliflozin may also contribute to modest weight reduction in some patients. However, individual results vary, and this medicine does not replace healthy eating, physical activity, or regular medical consultations. Dosage The dosage of Gliempaflozin 3D 10 should be determined by a qualified healthcare professional. Although the stated composition contains empagliflozin 10 mg, sitagliptin 100 mg, and metformin hydrochloride 1000 mg, the appropriate regimen depends on kidney function, previous treatment, and the specific formulation. Take the medicine exactly as prescribed and follow the product's instructions. Metformin-containing formulations are commonly taken with meals to reduce stomach discomfort, but the correct timing depends on the formulation. Do not change the dose, double a missed dose, or combine it with other diabetes medicines without medical advice. Side Effects Possible side effects of Gliempaflozin 3D 10 include nausea, diarrhoea, abdominal discomfort, increased urination, thirst, headache, and genital fungal infections. Urinary tract infections may also occur. Low blood sugar is more likely when the medicine is combined with insulin or sulfonylureas. Seek urgent medical attention for severe abdominal pain, persistent vomiting, unusual breathing difficulty, or signs of a serious allergic reaction. These symptoms may indicate a serious complication requiring prompt treatment. Precautions and Warnings Inform your doctor about kidney problems, allergies, existing medical conditions, and all medicines you take. Maintain adequate hydration unless medically advised otherwise. Seek medical guidance during severe illness, dehydration, or before surgery because temporary treatment interruption may be necessary. Discuss pregnancy and breastfeeding with your healthcare professional. Avoid excessive alcohol consumption because it may increase the risk of serious complications associated with metformin. Kidney function should be assessed regularly. Symptoms of ketoacidosis require urgent evaluation, even if blood glucose is not markedly elevated. Conclusion Gliempaflozin 3D 10 combines empagliflozin 10 mg, sitagliptin 100 mg, and metformin hydrochloride 1000 mg to support the management of type 2 diabetes. When appropriately prescribed, it may help improve blood glucose control through three complementary mechanisms. Consult a healthcare professional before starting treatment and follow the prescribed dosage and monitoring plan.